Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 7, Number 4, April 2015, pages 248-252


Serum Survivin Increases in Prolactinoma

Table

Table 1. Baseline Clinical Features of Prolactinoma Patients and Healthy Controls
 
Patients group (n = 25)Control group (n = 21)P
BMI: body mass index; ALT: alanin aminotranspherase; TSH: thyroid stimulating hormone. Mann-Whitney U test was used. Values are expressed as median (minimum-maximum). *Results are statistically significant (P < 0.05).
Age (years)34 (17 - 51)35 (22 - 45)0.921
BMI (kg/m2)27.4 (17.7 - 37.4)25.7 (16.2 - 47.2)0.400
Glucose (mg/dL)87 (77 - 132)90 (77 - 107)0.408
Creatinine (mg/dL)0.82 (0.67 - 1.01)0.84 (0.67 - 1.07)0.748
ALT (U/L)27 (18 - 51)32 (22 - 49)0.169
TSH (mIU/L)1.84 (0.35 - 3.72)1.69 (0.35 - 4.68)0.332
Prolactin (ng/mL)5.09 (0.24 - 12.00)17.38 (10.94 - 24.05)< 0.001*
Survivin (pg/mL)19.04 (10 - 38)15.05 (8 - 22)0.042*